Biodiversity : new leads for the pharmaceutical and agrochemical industries /
This product is not available separately, it is only sold as part of a set. There are 750 products in the set and these are all sold as one entity.
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Conference Proceeding eBook |
| Language: | English |
| Published: |
Cambridge :
Royal Society of Chemistry,
[2000]
|
| Series: | Special publication (Royal Society of Chemistry (Great Britain)) ;
no. 257. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Microbial natural products : a past with a future
- New concepts and approaches to biodiversity
- Nature products drug discovery at the National Cancer Institute : past achievements and new directions for the new millennium
- Secondary metabolites as a vital source of animal health products
- The relationship between natural products and synthetic chemistry in the discovery process
- Natural products vs. combinatorials : a case study
- Mushrooms, microbes and medicines
- Signal transduction inhibitors from microorganisms
- Novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579
- Marine organisms as a source of novel lead structures for drug development
- The anticancer dolastatins as cyanobacterial metabolites
- A Cu² selective marine metabolite
- Water soluble bioactive alkaloids
- "Lessons from nature" : can ecology provide new leads in the search for novel bioactive chemicals from tropical rainforests?
- Brazilian biodiversity : a source of phytomedicines, natural drugs and leads for the pharmaceutical and agrochemical industries
- A modern perspective to the traditional use of plants in the highlands of Scotland
- In vivo and in vitro biosynthetic studies : Understanding and exploiting natural pathways
- Fused ring aromatic polyketides are formed by different cyclisation pathways in fungi and streptomycetes
- The strobilurin fungicides : from mushroom to molecule to market
- A synthesis of (+)prelog-Djerassi lactonic acid
- N-([alpha]-aminoacyl)-5'-O-sulfamoyladenosines : natural product based inhibitors of amino acyl tRNA synthetases.